← Back to Patent Explorer
US4409233A Expired / Lapsed US ⏱️ 0.0 years remaining

Highly concentrated preparations of dopa compounds

Assignee: Sankyo Co Ltd
•
Filing: 1979-07-02
•
Granted: 1983-10-11
•
Expires: 1999-07-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A highly concentrated aqueous composition of a dopa which comprises a dopa and at least one amino acid selected from the group consisting of methionine, proline, hydroxyproline, serine, threonine, valine, arginine, lysine, histidine and ornithine. Said composition having a concentration of said amino acid of 1-300 mg per ml of said aqueous solution of a dopa compound.

Inventors

  • 👤 Kazuhiro Tsukada
  • 👤 Wataru Kato

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 07:28
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K47/00; A61K47/06; A61K47/16; A61K47/18; A61K47/183; A61K47/20; A61P; A61P25/00; A61P9/00; A61P9/12

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 53 words
A highly concentrated aqueous composition of a dopa which comprises a dopa and at least one amino acid selected from the group consisting of methionine, proline, hydroxyproline, serine, threonine, valine, arginine, lysine, histidine and ornithine, said composition having a concentration of said amino acid of 1-300 mg per ml of said aqueous composition.
Claim 2
Dependent Claim 53 words
A highly concentrated aqueous composition of a dopa which comprises a dopa and at least one amino acid selected from the group consisting of methionine, proline, hydroxyproline, serine, threonine, valine, arginine, lysine, histidine and ornithine, said composition having a concentration of said amino acid of 1-300 mg per ml of said aqueous composition.
Claim 3
Dependent Claim 10 words
The composition of claim 1 wherein said dopa is L-3-(3,4-dihydroxyphenyl)-2-methylalanine.
Claim 4
Dependent Claim 10 words
The composition of claim 1 wherein said dopa is β-(3,4-dihydroxyphenyl)-α-alanine.
Claim 5
Dependent Claim 11 words
The composition of claim 3 wherein said amino acid is arginine.
Claim 6
Dependent Claim 11 words
The composition of claim 3 wherein said amino acid is lysine.
Claim 7
Dependent Claim 11 words
The composition of claim 3 wherein said amino acid is histidine.
Claim 8
Dependent Claim 11 words
The composition of claim 3 wherein said amino acid is ornithine.
Claim 9
Dependent Claim 11 words
The composition of claim 2 wherein said amino acid is arginine.
Claim 10
Dependent Claim 11 words
The composition of claim 2 wherein said amino acid is lysine.
Claim 11
Dependent Claim 11 words
The composition of claim 2 wherein said amino acid is histidine.
Claim 12
Dependent Claim 11 words
The composition of claim 2 wherein said amino acid is ornithine.
Claim 13
Dependent Claim 11 words
The composition of claim 1 wherein said amino acid is arginine.
Claim 14
Dependent Claim 11 words
The composition of claim 1 wherein said amino acid is lysine.
Claim 15
Dependent Claim 11 words
The composition of claim 1 wherein said amino acid is histidine.
Claim 16
Dependent Claim 11 words
The composition of claim 1 wherein said amino acid is ornithine.
Claim 17
Dependent Claim 63 words
A freeze-dried composition of a dopa which comprises a dopa and at least one amino acid selected from the group consisting of methionine, proline, hydroxyproline, serine, threonine, valine, arginine, lysine, histidine and ornithine, said composition having been prepared by freeze-drying a concentrated aqueous composition comprising said dopa and said amino acid in an amount of 1-300 mg per ml of said aqueous composition.
Claim 18
Dependent Claim 63 words
A freeze-dried composition of a dopa which comprises a dopa and at least one amino acid selected from the group consisting of methionine, proline, hydroxyproline, serine, threonine, valine, arginine, lysine, histidine and ornithine, said composition having been prepared by freeze-drying a concentrated aqueous composition comprising said dopa and said amino acid in an amount of 1-300 mg per ml of said aqueous composition.

References Cited (Backward Citations)

US3911137A Cited
US4321264A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-10-10 1987-04-11 1987-10-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-10-10 1991-04-11 1991-10-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-10-10 1995-04-11 1995-10-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag